1. Home
  2. ANVS vs MAMK Comparison

ANVS vs MAMK Comparison

Compare ANVS & MAMK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANVS
  • MAMK
  • Stock Information
  • Founded
  • ANVS 2008
  • MAMK 2007
  • Country
  • ANVS United States
  • MAMK China
  • Employees
  • ANVS N/A
  • MAMK N/A
  • Industry
  • ANVS Biotechnology: Pharmaceutical Preparations
  • MAMK Apparel
  • Sector
  • ANVS Health Care
  • MAMK Consumer Discretionary
  • Exchange
  • ANVS Nasdaq
  • MAMK Nasdaq
  • Market Cap
  • ANVS 46.1M
  • MAMK 52.9M
  • IPO Year
  • ANVS 2020
  • MAMK 2025
  • Fundamental
  • Price
  • ANVS $2.05
  • MAMK $5.46
  • Analyst Decision
  • ANVS Strong Buy
  • MAMK
  • Analyst Count
  • ANVS 4
  • MAMK 0
  • Target Price
  • ANVS $17.33
  • MAMK N/A
  • AVG Volume (30 Days)
  • ANVS 1.3M
  • MAMK 487.4K
  • Earning Date
  • ANVS 11-12-2025
  • MAMK 11-13-2025
  • Dividend Yield
  • ANVS N/A
  • MAMK N/A
  • EPS Growth
  • ANVS N/A
  • MAMK N/A
  • EPS
  • ANVS N/A
  • MAMK 0.12
  • Revenue
  • ANVS N/A
  • MAMK $21,434,100.00
  • Revenue This Year
  • ANVS N/A
  • MAMK N/A
  • Revenue Next Year
  • ANVS N/A
  • MAMK N/A
  • P/E Ratio
  • ANVS N/A
  • MAMK $43.76
  • Revenue Growth
  • ANVS N/A
  • MAMK N/A
  • 52 Week Low
  • ANVS $1.11
  • MAMK $1.87
  • 52 Week High
  • ANVS $10.54
  • MAMK $7.58
  • Technical
  • Relative Strength Index (RSI)
  • ANVS 47.27
  • MAMK N/A
  • Support Level
  • ANVS $1.97
  • MAMK N/A
  • Resistance Level
  • ANVS $2.23
  • MAMK N/A
  • Average True Range (ATR)
  • ANVS 0.18
  • MAMK 0.00
  • MACD
  • ANVS 0.02
  • MAMK 0.00
  • Stochastic Oscillator
  • ANVS 45.15
  • MAMK 0.00

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

About MAMK MaxsMaking Inc. Class A Ordinary Shares

MaxsMaking Inc is a manufacturer of consumer goods with a focus on technology and innovation. It is serving small and medium-sized enterprises and individual e-commerce sellers with their needs for small batch products, It currently use cotton cloth, nylon cloth, polyester, recycled polyethylene terephthalate (rPET) and other materials to produce backpacks, shopping bags, aprons, tablecloths and other consumer goods. It serve enterprises, schools, government agencies, non-profit organizations, e-commerce sellers and various groups and organizations to meet their needs for small-batch products.

Share on Social Networks: